3,3-DIFLUORO-1-HYDROXYCYCLOBUTANE-1-CARBOXYLIC ACID, 95%, 250mg

Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate, 98%, 500g

1H-Pyrazolo[4,3-b]pyridin-3(2H)-one, 95.0%, 250mg

3-Methylsalicylic acid, min. 98.5%, for synthesis, 100 g, glass packaging

N-(4-Oxocyclohexyl)phthalimide>98.0%(GC)(N)5g

1-(2-Pyridyl)-2-thiourea, 98.0%, 10g

(6R,7R)-3-(Acetoxymethyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 95.0%, 500g

Fmoc-(R)-3-Amino-4-(3-thienyl)-butyric acid, 98%, 250mg

5-(Difluoromethyl)-N-[5-({[(2S)-3,3-dimethylbutan-2-yl]amino}methyl)-1-{[(2S)-1-(prop-2-enoyl)pyrrolidin-2-yl]methyl}-1H-1,3-benzodiazol-2-yl]thiophene-2-carboxamide, 98%, 100mg

Ethyl 5-amino-2-chloronicotinate, 97%, 250mg

1-(Chloromethyl)-4-(octyloxy)benzene, 98%, 5g

Volumetric flasks class A Clear glass, 20 ml, 10/19, 2 Piece(s)

4-Methoxy-2-methylpyridine, 95.0%, 100g